Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714919 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study: a Non-opioid Technique for Postoperative Adenoidectomy Pain Relief in Pediatric Patients
A Phase 2 study of Adenoid Hypertrophy, sponsored by Arlyne Thung.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03714919: Completed Phase 2 study of Adenoid Hypertrophy, sponsored by Arlyne Thung.
NCT03714919 is a Phase 2 study of Adenoid Hypertrophy that has completed, run by Arlyne Thung. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03714919, a Phase 2 study of Adenoid Hypertrophy, has completed, sponsored by Arlyne Thung.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study will assess analgesic efficacy of a multi-modal, non-opioid analgesic regimen for providing surgical analgesia in pediatric patients undergoing adenoidectomy and to assess recovery characteristics in the post-anesthesia care unit (PACU) and at home following surgery.
Primary Outcome
Visual Analogue Scale (VAS) pain scores (0 being no pain and 10 being worst pain) in post-anesthesia care unit (PACU).
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ketamine
- DRUG Dexmedetomidine
- DRUG Dextromethorphan
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-08-02 |
| Est. Completion | 2019-11-10 |
| Phase | Phase 2 |
What the finished NCT03714919 record still lists
NCT03714919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Adenoid Hypertrophy appearing as the primary indexed condition, and to 4 interventions - of which Acetaminophen is the first listed.
NCT03714919 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03714919 about?
NCT03714919 is a clinical study titled "A Pilot Study: a Non-opioid Technique for Postoperative Adenoidectomy Pain Relief in Pediatric Patients". This proposed study will assess analgesic efficacy of a multi-modal, non-opioid analgesic regimen for providing surgical analgesia in pediatric patients undergoing adenoidectomy and to assess recovery characteristics in the post-anesthesia care unit (PACU) and at home following surgery.
What is the current status of trial NCT03714919?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2019-08-02. Estimated completion is 2019-11-10.
What conditions does trial NCT03714919 study?
This clinical trial studies the following conditions: Adenoid Hypertrophy.
What interventions are being tested in trial NCT03714919?
The interventions under investigation include: Acetaminophen (DRUG), Ketamine (DRUG), Dexmedetomidine (DRUG), Dextromethorphan (DRUG).
Who is sponsoring clinical trial NCT03714919?
This trial is sponsored by Arlyne Thung, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03714919 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenoid Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03714919's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI